Patrick J. Moore

Patrick J. Moore

Auto-generated profile, based on publicly available information

Patrick J. Moore

Affiliation Department of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, United States of America

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2021 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
JFJessica K. Fiege
Jessica K. Fiege
JTJoshua M. Thiede
Joshua M. Thiede
HNHezkiel Arya Nanda
Hezkiel Arya Nanda
WMWilliam Matchett
William Matchett
PMPatrick J. Moore
Patrick J. Moore
RLRyan Langlois
Ryan Langlois
The human airway epithelium is the initial site of SARS-CoV-2 infection. We used flow cytometry and single cell RNA-sequencing to understand how the heterogeneity of this diverse cell population contributes to elements of viral tropism and pathogenesis, antiviral immunity, and treatment response to remdesivir. We found that, while a variety of epithelial cell types are susceptible to infection, ciliated cells are the predominant cell target of SARS-CoV-2. The host protease TMPRSS2 was required for infection of these cells. Importantly, remdesivir treatment effectively inhibited viral replication across cell types, and blunted hyperinflammatory responses. Induction of interferon responses within infected cells was rare and there was significant heterogeneity in the antiviral gene signatures, varying with the burden of infection in each cell. We also found that heavily infected secretory cells expressed abundant IL-6, a potential mediator of COVID-19 pathogenesis.